Home / Knowledge Centre /
Technical Sheet

Almac Clinical Technologies Biostatistics Group

Almac is uniquely positioned with a dedicated Biostatistics Group who are 100% focused on Randomisation and IXRS® Implementation / Support. The Biostatistics Group is comprised of experienced Biostatisticians and Biostatistics Data Managers.

Almac’s Biostatistics group offers randomisation consultancy upfront and across the study’s lifecycle:

• Regulatory considerations of randomisation
• Evaluation of blinding / potential for selection-bias
• Selection of randomisation methodology and parameterisation
• Treatment balance impact
• IXRS® randomisation solutions for any type of study (from simple to complex)

 

Learn more by downloading our fact sheet.

View Resource

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies